jama glp-1 📌 Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no First Time: Orally Available GLP-1

Phase 2 trial (NEJM 2023) used a structured ramp to 12 mg/week but at trial doses of 8 mg and 12 mg, dropout from gastrointestinal events was substantial

Can PlexusDx help if my BCBS plan denies Wegovy coverage

Neuropsychologia, 41, 184-194

Pure Nutrition's Lipomax combines 580mg of glutathione with vitamin C in one capsule for exactly this reason

With a $20m market cap and no debt, iBio is essentially a pure bet that a leading cardiometabolic team + aligned investors will be able to develop and partner on an attractive myostatin inhibition compound before 2026

Standard oral glutathione products tend to be poorly absorbed due to the action of an intestinal enzyme which has the potential to degrade glutathione